Wells Pharmacy Network completes 503A building expansion

Published: 30-Jan-2017

The pharmacy is among the first in the US to build negative pressure hazardous chemical storage rooms and cleanrooms as per the new USP General Chapter 800 guidelines


Wells Pharmacy Network has completed a multi-million dollar 5,000ft2 expansion and facility enhancement of its existing 16,000ft2 503A compounding pharmacy located in Ocala, Florida.

The move is intended to meet the growing demand of physicians and patients throughout the US for high-quality human anti-aging and wellness compounded medications, and will expand its Pharmacy Operations, Quality Assurance, Customer Service, and Shipping departments.

Ben David, President & CEO of Wells Pharmacy Network said: “Businesses operating in the compounding pharmaceutical industry currently are faced with the need to execute with a different skill set than they have historically possessed.

"Companies that wish to be successful, in the short run as well as in the future, must adapt to this ever-changing environment. To meet these demands, both market driven and regulatory, businesses in the compounding pharmacy industry must invest in both personnel and infrastructure.

"Wells Pharmacy Network has always been committed to providing the highest quality products and service to all of our customers. The expansion of our 503A facilities are a testament to our commitment to continue to be one of the leaders in this industry.”

The privately held 503A compounding pharmacy has locations in Ocala, Florida and Dyersburg, Tennessee and a corporate office in Wellington, Florida.

The company says it is among the first in the country to build negative pressure hazardous chemical storage rooms and negative pressure hazardous cleanrooms in accordance with the new USP General Chapter 800 guidelines, providing standards to protect compounding personnel when handling hazardous drugs.

The expansion also focused on equipment and process enhancements to Wells Pharmacy’s in-house endotoxin, sterility, potency, method suitability, and particulate testing. New equipment includes:

  • Biological safety cabinets (BSC) for compounding hazardous materials
  • Class 100 laminar airflow hoods inside the cleanrooms
  • Advanced HVAC systems
  • Continuous environmental monitoring system
  • Motion detector door systems

Wells Pharmacy says it has always invested in quality and safety and continues to use:

  • Third party independent testing to validate in-house test methods
  • Chemicals purchased through FDA registered facilities
  • Five-point quality control process
  • Images of the contents of every order captured during packing and shipping
  • Experienced clinical pharmacists and registered pharmacy technicians to process and verify all prescription orders
  • PhD Biochemist on site to manage Quality Control laboratory testing process
  • Sterility reports available upon request for every order

You may also like